German pharmaceutical company Bayer AG (BAYN.XE) Thursday said it has bought privately held pharmaceutical firm Steigerwald Arzneimittelwerk GmbH in Darmstadt.

FRANKFURT, May 16 (Reuters) - Germany's largest drugmaker Bayer said it agreed to buy privately held Steigerwald Arzneimittelwerk GmbH, a maker of herbal treatments.

Federal regulators approved a new drug Wednesday from Bayer to treat certain types of advanced prostate cancer.

FRANKFURT, May 15 (Reuters) - German drugmaker Bayer and its development partner Algeta won approval from U.S. regulators for a prostate cancer drug that could eventually generate more than 1 billion euros ($1.31 billion) in annual sales.

FRANKFURT, May 15 (Reuters) - German drugmaker Bayer and its development partner Algeta wonapproval from U.S. regulators for a prostate cancer drug thatcould eventually generate more than 1...

FRANKFURT, May 15 (Reuters) - German drugmaker Bayer and its development partner Algeta won approval from U.S. regulators for a prostate cancer drug that could eventually generate more than 1 billion euros ($1.31 billion) in annual sales.

Federal regulators approved a new drug Wednesday from Bayer AG (BAYN.XE, BAYRY) to treat certain types of advanced prostate cancer.

FRANKFURT, May 15 (Reuters) - German drugmaker Bayer said on Wednesday it initiated a Phase III trial of its potential blockbuster drug regorafenib in patients with advanced liver cancer.

LEVERKUSEN, Germany (Reuters) - Bayer suggested there was room to lift prices at its high-tech plastics and chemicals business this year to counter soaring raw material costs that squeezed first quarter margins.

Bayersuggested there was room to lift prices at its high-tech plastics and chemicals business this year to counter soaring raw material costs that squeezed first quarter margins.

SAN ANTONIO, May 9 (Reuters) - Several hundred people have been evacuated from a section of Lubbock, Texas, after a leaking tank released a chemical that could turn into highly corrosive hydrochloric acid, the city's Fire Department said on Thursday.

SAN ANTONIO, May 9 (Reuters) - Several hundred people havebeen evacuated from a section of Lubbock, Texas, after a leakingtank released a chemical that could turn into highly corrosivehydrochloric acid, the city's Fire Department said on Thursday.

SAN ANTONIO, May 9 (Reuters) - Several hundred people have been evacuated from a section of Lubbock, Texas, after a leaking tank released a chemical that could turn into highly corrosive hydrochloric acid, the city's Fire Department said on Thursday.

Good morning, AdLand. Here's what you need to know today: Bayer is facing threats of a lawsuit over its One A Day marketing. The litigious Center for Science in the Public Interest sent the company a letter asking it to change its claims th

FRANKFURT, May 6 (Reuters) - A court ruled that Bayer did not pay some former Schering shareholders enough to acquire its German rival in 2007 and must now pay them more than 300 million euros ($392 million) in compensation, lawyers for the sharehold

German pharmaceutical company Bayer AG (BAYN.XE) said Friday it has discontinued a Phase II/III trial for its BAY 86-6150 compound in people with hemophilia A and hemophilia B who have developed neutralizing antibodies "Due to safety concerns, we are

FRANKFURT, May 3 (Reuters) - Bayer said its HealthCare division stopped a Phase II/III study testing its experimental treatment BAY 86-6150 on certain haemophilia A and B patients due to safety concerns.

By The Value Investor: Shares of Conceptus (CPTS) rose 19.5% in Monday's trading session. The developer and marketer of the flagship Essure permanent birth control procedure reported its first quarter results for 2013. More importantly, Conceptus ann

German chemicals and pharmaceuticals group Bayer said it would acquire California-based Conceptus to bolster its flagging contraceptives business in a deal that values the company at $1.1 billion.

Here are the top stock stories making waves on Monday morning...

NEW YORK, April 29 (Reuters) - Conceptus Inc : * Shares up 20 percent in premarket trading, Bayer to buy company

NEW YORK, April 29 (Reuters) - Conceptus Inc : * Shares up 20 percent in premarket trading, Bayer to buy company

NEW YORK, April 29 (Reuters) - Conceptus Inc : * Shares up 20 percent in premarket trading, Bayer to buy company

Conceptus (NASDAQ: CPTS) soared 19.77% to $31.02 in the pre-market trading after Bayer AG agreed to acquire the company for about $1.1 billion.

Bayer AG (BAYRY, BAYN.XE) has agreed to buy Conceptus Inc. (CPTS) for about $1.1 billion (852 million euros) as the health-care firm aims to broaden its women's contraceptive offerings.

Bayer AG (BAYRY, BAYN.XE) has agreed to buy Conceptus Inc. (CPTS) for about $1.1 billion (852 million euros) as the health-care firm aims to broaden its women's contraceptive offerings.

The German chemicals and pharmaceuticals group will acquire Conceptus in a deal that values the company at $1.1 billion, to bolster its flagging contraceptives business.

Germany's Bayer plans to buy US contraceptive maker Conceptus as it attempts to increase its range of female healthcare products.

Conceptus (NASDAQ: CPTS) announced today that Conceptus has signed a definitive merger agreement with Bayer HealthCare LLC, Leverkusen, Germany.With this acquisition, Bayer will be able to offer a complete range of short-term, long-term and permanent

The pharmaceutical giant Bayer plans to buy the American birth control device manufacturer Conceptus for $1.1 billion. The German company said it would offer Conceptus' shareholders $31 for each of their shares in the company, which represents a 20 p

MADRID (MarketWatch) -- Bayer AGon Monday said it will buy Conceptus, Inc. , whose flagship product is a surgery-free permanent birth control method, for $1.1 billion. Bayer intends to extend its range of short-term, long-term and permanent contracep

FRANKFURT (Reuters) - Germany's Bayer AG has agreed to buy U.S. contraceptive devices maker Conceptus for $1.1 billion, aiming to underpin its position as the world's largest women's healthcare provider,

Germany's Bayer AGhas agreed to buy U.S. contraceptive devices maker Conceptusfor $1.

* Purchase of Concetpus is latest in string of bolt-on deals

* Purchase of Concetpus is latest in string of bolt-on deals

German drug maker buying U.S. company that produces irreversible birth control product.

FRANKFURT, April 29 (Reuters) - Germany's Bayer agreed to acquire U.S. birth-control devices company Conceptus for $1.1 billion in cash, to cement its position as the world's largest women's healthcare provider.

FRANKFURT, April 29 (Reuters) - Germany's Bayer agreed to acquire U.S. birth-control devices company Conceptus for $1.1 billion in cash, to cement its position as the world's largest women's healthcare provider.

Bayer AG (BAYRY.PK)Q1 2013 Earnings CallApril 25, 20138:00 am ETExecutivesAlexander Rosar - Head of Investor RelationsMarijn E. Dekkers - Chairman of Management Board and Chief Executive OfficerWolfgang Plischke - Member of Management Board and Chief

AstraZeneca said profit fell for a fifth-consecutive quarter as patent expiries hit the drug company, while Germany's Bayer was boosted by pharmaceutical-product sales and its agrochemical division.

* Hit by higher raw-material costs, global supply overhang

Bayer AG (BAYN.XE) Thursday confirmed its outlook for the year as it reported a rise in first-quarter earnings, supported by growth at the HealthCare and CropScience units.

FRANKFURT, April 25 (Reuters) - Quarterly underlying core earnings at Bayer, Germany's largest drugmaker, edged 0.4 percent higher as strong demand for its farming pesticides was offset by high raw material costs at its plastics and chemicals unit.

The following is a summary of analysts' forecasts for Bayer AG (BAYN.XE) first-quarter results, based on a poll of 13 analysts conducted by Dow Jones Newswires (figures in million euros, EPS, dividend and target price in euro, according to IFRS).

The UK's healthcare cost-effectiveness body known as National Institute for Health and Care Excellence, or NICE, Friday recommended German pharmaceutical company Bayer AG's (BAYN.XE) anti-clotting drug Xarelto for the treatment of pulmonary embolism.

FRANKFURT, April 18 (Reuters) - Drugs from Novo Nordisk , Amgen, Bayer and other companies could face price cuts in Germany as the country's medical cost-benefit agency widens a review into the value offered by medicines.

WASHINGTON, April 16 (Reuters) - A U.S. appeals court hasruled against Bayer AG, a world leader in oralcontraceptives, reversing a ruling by a lower court and findingthat parts of a patent for the German drugmaker's Yaz birthcontrol pill were invalid